News

Santiago, Chile – June 2026 Q-VANT Biosciences is pleased to announce the commercial launch of QS-21…

Q-VANT Biosciences Supports $1.65M Gates Foundation–Funded Program Led by Tulane University to Advance Next-Generation Oral…

Q-VANT new state-of-the-art manufacturing facility is officially ready to start production! This cutting-edge site leverages our…

Q-Vant Biosciences Inc., a biosciences company specialized in manufacturing and formulating open-access saponin-based adjuvants from…

Enhances Q-VANT’s 100% sustainable supply for next-generation saponin adjuvants   Boston, MA – March 8,…

The Quillaja saponaria tree is a slow-growing evergreen native to Chile whose bark has long been used…

Q-VANT Biosciences launched recently as the first company to use a computational-driven approach to solve the…

Bruce Forrest recently joined the Q-VANT team as Chief Scientific Officer, bringing more than two…